This article is
- freely available
MiRNAs and LincRNAs: Could They Be Considered as Biomarkers in Colorectal Cancer?
Laboratory of Pharmacogenomics, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona-Navarra 31008, Spain
Laboratory of Clinical Genetics, University of Navarra, Pamplona 31008, Spain
Laboratory of Immunology, Service of Hematology, Complejo Hospitalario de Navarra, Pamplona 31008, Spain
Unit for the Research and Treatment of Gastrointestinal Malignancies, Department of Medical Oncology, University Clinic of Navarra (CUN), Pamplona-Navarra 31008, Spain
* Author to whom correspondence should be addressed.
Received: 2 November 2011; in revised form: 15 December 2011 / Accepted: 28 December 2011 / Published: 16 January 2012
Abstract: Recent advances in the field of RNA research have provided compelling evidence implicating microRNA (miRNA) and long non-coding RNA molecules in many diverse and substantial biological processes, including transcriptional and post-transcriptional regulation of gene expression, genomic imprinting, and modulation of protein activity. Thus, studies of non-coding RNA (ncRNA) may contribute to the discovery of possible biomarkers in human cancers. Considering that the response to chemotherapy can differ amongst individuals, researchers have begun to isolate and identify the genes responsible. Identification of targets of this ncRNA associated with cancer can suggest that networks of these linked to oncogenes or tumor suppressors play pivotal roles in cancer development. Moreover, these ncRNA are attractive drug targets since they may be differentially expressed in malignant versus normal cells and regulate expression of critical proteins in the cell. This review focuses on ncRNAs that are differently expressed in malignant tissue, and discusses some of challenges derived from their use as potential biomarkers of tumor properties.
Keywords: biomarkers; cancer; prognostic; non-coding RNA
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Zarate, R.; Boni, V.; Bandres, E.; Garcia-Foncillas, J. MiRNAs and LincRNAs: Could They Be Considered as Biomarkers in Colorectal Cancer? Int. J. Mol. Sci. 2012, 13, 840-865.
Zarate R, Boni V, Bandres E, Garcia-Foncillas J. MiRNAs and LincRNAs: Could They Be Considered as Biomarkers in Colorectal Cancer? International Journal of Molecular Sciences. 2012; 13(1):840-865.
Zarate, Ruth; Boni, Valentina; Bandres, Eva; Garcia-Foncillas, Jesús. 2012. "MiRNAs and LincRNAs: Could They Be Considered as Biomarkers in Colorectal Cancer?" Int. J. Mol. Sci. 13, no. 1: 840-865.